EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,326,000 | -54.1% | 464,694 | -44.1% | 0.42% | -60.1% |
| Q3 2020 | $20,319,000 | +3.9% | 831,051 | +0.9% | 1.04% | -7.8% |
| Q2 2020 | $19,560,000 | +41.0% | 823,925 | +2.3% | 1.13% | +1.3% |
| Q1 2020 | $13,872,000 | -2.3% | 805,562 | -0.1% | 1.12% | +29.1% |
| Q4 2019 | $14,204,000 | +0.2% | 806,113 | +0.6% | 0.87% | -8.6% |
| Q3 2019 | $14,176,000 | -17.4% | 801,560 | -0.2% | 0.95% | -13.6% |
| Q2 2019 | $17,160,000 | -8.6% | 802,984 | +1.8% | 1.10% | -14.0% |
| Q1 2019 | $18,781,000 | +28.7% | 789,134 | +6.3% | 1.28% | +7.3% |
| Q4 2018 | $14,598,000 | +9.0% | 742,137 | -1.8% | 1.19% | +28.5% |
| Q3 2018 | $13,389,000 | +7.3% | 755,582 | +30.3% | 0.93% | -8.0% |
| Q2 2018 | $12,482,000 | +50.0% | 580,022 | +54.4% | 1.01% | -9.4% |
| Q1 2018 | $8,321,000 | – | 375,671 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |